Search research articles
Contact Us
Filters
Showing results (1-10 of 112) with videos related to
Page
of 12
Sort By:
Current Urology
|
January 24, 2022
Combined DNA repair defects in testicular metastasis from prostate cancer sensitize to immune checkpoint blockade
Panagiotis J Vlachostergios
Translational Cancer Research
|
April 14, 2025
Circulating tumor cell-based PSMA and PSA expression as a predictive and prognostic tool in prostate cancer
Panagiotis J Vlachostergios
Exploration of Targeted Anti-Tumor Therapy
|
December 1, 2025
Cancer vaccines: advances, hurdles, and future directions
Panagiotis J Vlachostergios
Precision Clinical Medicine
|
June 13, 2022
The interplay of cell cycle and DNA repair gene alterations in upper tract urothelial carcinoma: predictive and prognostic implications
Panagiotis J Vlachostergios
Expert Review of Anticancer Therapy
|
July 4, 2025
PSMA PET or conventional imaging in metastatic hormone-sensitive prostate cancer?
Panagiotis J Vlachostergios
Journal of Kidney Cancer and VHL
|
September 28, 2020
Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation
Panagiotis J Vlachostergios
American Journal of Translational Research
|
December 27, 2021
Integrin signaling gene alterations and outcomes of cancer patients receiving immune checkpoint inhibitors
Panagiotis J Vlachostergios
Translational Oncology
|
April 15, 2021
Loss of tumor suppressive properties of lipid metabolism enzyme CPT2 in ovarian carcinoma: Comment on "CPT2 down-regulation promotes tumor growth and metastasis through inducing ROS/NFκB pathway in ovarian cancer" by Zhang et al
Panagiotis J Vlachostergios
Molecular Cancer Therapeutics
|
May 20, 2014
Efficacy of zibotentan in colorectal cancer--letter
Panagiotis J Vlachostergios
Urologic Oncology
|
July 30, 2025
Leveraging DNA repair deficiency to personalize radiopharmaceutical therapy in prostate cancer
Panagiotis J Vlachostergios
Page
of 12
Search research articles
Search
Showing results (1-10 of 112) with videos related to
Sort By:
Page
of 12
Current Urology
|
January 24, 2022
Combined DNA repair defects in testicular metastasis from prostate cancer sensitize to immune checkpoint blockade
Panagiotis J Vlachostergios
Translational Cancer Research
|
April 14, 2025
Circulating tumor cell-based PSMA and PSA expression as a predictive and prognostic tool in prostate cancer
Panagiotis J Vlachostergios
Exploration of Targeted Anti-Tumor Therapy
|
December 1, 2025
Cancer vaccines: advances, hurdles, and future directions
Panagiotis J Vlachostergios
Precision Clinical Medicine
|
June 13, 2022
The interplay of cell cycle and DNA repair gene alterations in upper tract urothelial carcinoma: predictive and prognostic implications
Panagiotis J Vlachostergios
Expert Review of Anticancer Therapy
|
July 4, 2025
PSMA PET or conventional imaging in metastatic hormone-sensitive prostate cancer?
Panagiotis J Vlachostergios
Journal of Kidney Cancer and VHL
|
September 28, 2020
Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation
Panagiotis J Vlachostergios
American Journal of Translational Research
|
December 27, 2021
Integrin signaling gene alterations and outcomes of cancer patients receiving immune checkpoint inhibitors
Panagiotis J Vlachostergios
Translational Oncology
|
April 15, 2021
Loss of tumor suppressive properties of lipid metabolism enzyme CPT2 in ovarian carcinoma: Comment on "CPT2 down-regulation promotes tumor growth and metastasis through inducing ROS/NFκB pathway in ovarian cancer" by Zhang et al
Panagiotis J Vlachostergios
Molecular Cancer Therapeutics
|
May 20, 2014
Efficacy of zibotentan in colorectal cancer--letter
Panagiotis J Vlachostergios
Urologic Oncology
|
July 30, 2025
Leveraging DNA repair deficiency to personalize radiopharmaceutical therapy in prostate cancer
Panagiotis J Vlachostergios
Page
of 12